VX1 vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

VX1

by Volta Medical

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

Tool A (VX1) is designed for real-time assistance during cardiac ablation procedures, focusing on electrogram analysis for arrhythmias. In contrast, Tool B (ClearRead CT) specializes in diagnostic imaging analysis of CT scans, primarily for pulmonary nodule detection and coronary artery calcification scoring. While both contribute to cardiology, their distinct clinical applications and data inputs mean they address different stages of patient care.

Choose VX1 if…

Choose VX1 if your cardiac electrophysiology lab requires real-time AI assistance to identify dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. This tool is ideal for standardizing outcomes and reducing inter-operator variability in complex cardiac interventions.

View VX1 →

Choose ClearRead CT if…

Choose ClearRead CT if your radiology department needs to enhance diagnostic accuracy and efficiency in interpreting cardiothoracic CT scans. This AI suite is particularly well-suited for improving pulmonary nodule detection, including characterization and tracking, and for performing coronary artery calcification scoring on ungated, non-contrast CTs.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	VX1	ClearRead CT
Pricing	Contact for pricing	Contact for pricing
Deployment	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ClearRead CT

ClearRead CT explicitly highlights features that enhance usability, such as 'Reduced Reading Time (up to 36%)' and 'Streamlines radiology workflows,' directly addressing efficiency for the end-user. Its 'Seamless PACS Integration' and flexible deployment options (on-premise and cloud) also suggest broader and more adaptable integration into existing healthcare IT environments.

Clinical Value

ClearRead CT

While both tools are FDA-cleared and offer significant clinical benefits, ClearRead CT provides a quantifiable improvement in diagnostic accuracy with a '29% reduction in missed actionable nodules'. It also offers comprehensive features like automated nodule tracking and coronary artery calcification scoring, demonstrating a broad and measurable impact on patient care.

Pricing & Value

Tie

Both VX1 and ClearRead CT require potential customers to 'contact for pricing,' indicating a lack of public transparency regarding their cost structures. Without specific pricing details or comparative value propositions beyond their core functionalities, it is not possible to determine a winner in this dimension.

Enterprise Readiness

ClearRead CT

ClearRead CT offers more flexible deployment options, including both 'On-premise (stand-alone server, virtual machine) and Cloud,' catering to diverse IT infrastructures. Furthermore, it explicitly states that HIPAA compliance and BAA are 'likely' due to its operation with institutions like the VA, suggesting a higher level of readiness for large-scale healthcare deployments.

Innovation

VX1

VX1 demonstrates significant innovation by providing 'AI-guided real-time identification of dispersed electrograms' during complex cardiac ablation procedures, directly assisting in a live, interventional setting. Its ability to analyze '3D anatomical and electrical maps' and 'reduce inter-operator variability' in such a critical procedure represents a cutting-edge application of AI in a dynamic clinical environment.

Support & Docs

Tie

Neither the provided structured facts nor publicly available information from web searches explicitly detail the support structures, documentation, or customer service offerings for either VX1 or ClearRead CT. Therefore, it is not possible to differentiate between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	VX1	ClearRead CT
Name	VX1	ClearRead CT
Company	Volta Medical	RIVERAIN TECHNOLOGIES
Primary Use Case	Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.	Enhances pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Core AI Application	AI-guided real-time identification of dispersed electrograms (EGMs)	Pulmonary Nodule Detection (solid, part-solid, ground glass)
Additional Key Capability	Analyzes 3D anatomical and electrical maps of human atria	Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs)
Target Categories	Cardiology AI, Surgical AI	Cardiology AI, Oncology AI, Radiology & Imaging AI
Target Specialties	Cardiology	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring VX1 and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do VX1 and ClearRead CT integrate into distinct clinical workflows, and for which specific clinical scenarios is each tool best suited?

VX1 is designed for real-time assistance during cardiac ablation procedures, integrating with existing electrophysiology (EP) lab mapping and recording systems to help electrophysiologists identify dispersed electrograms. ClearRead CT, conversely, enhances diagnostic imaging workflows by integrating with PACS to improve pulmonary nodule detection and coronary artery calcification analysis in CT scans, primarily for radiologists, pulmonologists, and cardiologists reviewing images.

What is the expected depth of integration with electronic health record (EHR) systems for each tool, beyond their primary system integrations?

VX1 integrates with existing EP lab mapping and recording systems, suggesting its primary data flow is within the EP environment during procedures. ClearRead CT offers seamless PACS integration and structured reporting capabilities, which typically allows for findings to be pushed into the EHR, streamlining the documentation of diagnostic imaging results.

What specific accuracy and sensitivity metrics are provided for each tool to demonstrate their clinical efficacy?

VX1 is designed to reduce inter-operator variability and has a 'Booster mode for increased sensitivity' during AT or slow AF. ClearRead CT claims improved detection accuracy with a '29% reduction in missed actionable nodules' and reduced reading times by up to 36%.

What is the anticipated learning curve for physicians and staff, and how quickly can a practice expect to realize the benefits of each tool?

VX1 assists in real-time during complex ablation procedures, implying a learning curve for electrophysiologists to effectively incorporate AI-guided insights into their technique and standardize outcomes. ClearRead CT streamlines radiology workflows and improves diagnostic accuracy, suggesting a quicker time-to-value through reduced reading times and enhanced nodule detection in routine CT scan interpretation.

What audit-trail features are available in each tool to track AI-assisted findings and support clinical documentation and quality assurance?

The provided information does not explicitly detail specific audit-trail features for either VX1 or ClearRead CT. However, ClearRead CT does offer automated nodule tracking and comparison to prior exams, which contributes to a longitudinal record of findings.

What are the primary considerations for implementing each tool across multiple clinical sites or a large hospital network?

VX1's integration with existing EP lab systems suggests that multi-site rollout would involve ensuring compatibility and consistent setup across various EP labs. ClearRead CT, with its seamless PACS integration, vendor-neutral processing, and enterprise-wide deployment capabilities, indicates a flexible and scalable implementation across different radiology departments within a multi-site network.

Beyond standard compliance, what additional security measures or certifications do these tools offer to ensure data integrity and patient privacy?

The provided descriptions do not explicitly detail security measures beyond general compliance for either VX1 or ClearRead CT. However, Volta Medical states its overarching goal includes developing devices 'with the highest standards of data protection', and ClearRead CT operates with the VA and other healthcare institutions, implying robust security practices.